《Professor Wang Zhinong's visit》
Dr. Wang Zhinong visited RoJure Medical for exchange and discussion on the integration of cutting-edge life sciences and intelligent healthcare development
On May 24, 2025, RoJure Medicine welcomed a heavyweight visiting guest - Dr. Wang Zhinong, a medical doctor and molecular physiology and chemistry expert. As a scientist with profound expertise in the field of molecular endocrine research, Dr. Wang had in-depth exchanges and discussions with the R&D and product teams of Rouju Medicine on precision medicine, systematic health management, AI assisted clinical technology, and other areas during his visit.
Dr. Wang Zhinong holds a Doctor of Medicine degree, specializing in Molecular Physiological Biochemistry, and has long been committed to studying the molecular regulatory mechanisms of adrenal steroid hormone biosynthesis. From 1999 to 2002, Dr. Wang served as a postdoctoral researcher in the Endocrinology Laboratory at the University of Texas Southwestern Medical Center (Dallas), participating in and leading multiple international cutting-edge basic medical research projects. His research achievements have played an important role in exploring the mechanisms and treatment pathways of endocrine diseases.
During this visit, Dr. Wang conducted on-site research on several core projects of RoJure Medicine, including the ICU advanced life support system, micro hyperbaric oxygen chamber, and digital health management platform. He highly praised the company's systematic thinking and engineering implementation capabilities in integrating AI, big data, biomaterials, and clinical needs. He pointed out that the key to future healthcare lies in achieving a complete closed-loop from molecular mechanism analysis to multi organ system intervention, and RoJure Medicine is at the forefront of this direction.
During the discussion, the R&D leader of RoJure introduced the company's strategic vision of "Defining a New Health Moment" to Dr. Wang, as well as multiple clinical trials and technology transformation projects that are about to be implemented. Both parties exchanged views on multiple specific research directions, including AI assisted therapy pathway optimization, modeling of early screening mechanisms for hormone metabolism abnormalities, and fusion of physiological signals and molecular level data. They have preliminarily reached an intention for future collaborative research and joint breakthroughs.
Dr. Wang Zhinong's visit not only brought academic inspiration from an international perspective to RoJure's medical research team, but also injected new ideas into the company's continuous construction of an intelligent medical ecosystem from genes to systems, from cognition to intervention. RoJure Medicine will continue to position itself as an "intelligent physician" and work together with more outstanding scientists in the industry to explore the boundaries of the integration of life sciences and engineering technology, helping modern healthcare move towards a more precise, efficient, and people-oriented future.